CORONAVIRUS Oxford’s COVID-19 vaccine may be mass produced in 2020

The vaccine produced an immune response in early-stage clinical trials with no major side effect.

The lead developer for the University of Oxford’s COVID-19 vaccine, Sarah Gilbert, has revealed that the vaccine could be rolled out by the end of the year but there is no certainty.

The Oxford experimental vaccine which is done in collaboration with AstraZeneca produced an immune response in early-stage clinical trials with no major side effect, according to data that was displayed on Monday. This development provides the hope that it could be in use before the end of the year.

According to report from Reuters, Sarah Gilbert in her discussion with BBC Radio said, ‘’The end of the year target for getting vaccine rollout, it’s a possibility but there’s absolutely no certainty about that because we need three things to happen.”


Sarah Gilbert pointed out that it needed to be shown to work at the late-stage trials, there needed to be large quantities manufactured and regulators had to agree quickly to license it for emergency use.

We are going there